LAB — Standard Biotools Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Standard Biotools, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	58.6	68.5	28.5	166	115
Net Total Accounts Receivable
Net Total Receivables	19	25.4	18.3	17.3	19.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	96.1	118	72.1	209	158
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12.9	55.6	65.2	59.5	54.9
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	265	325	275	390	323
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	32.8	54.2	49.6	43.4	109
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	111	186	181	161	160
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	154	139	94.6	230	163
Total Liabilities & Shareholders' Equity	265	325	275	390	323
Total Common Shares Outstanding